Literature DB >> 3899122

Aromatase inhibition and its pharmacologic implications.

A M Brodie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899122     DOI: 10.1016/0006-2952(85)90337-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  12 in total

Review 1.  Formation and Cleavage of C-C Bonds by Enzymatic Oxidation-Reduction Reactions.

Authors:  F Peter Guengerich; Francis K Yoshimoto
Journal:  Chem Rev       Date:  2018-06-22       Impact factor: 60.622

Review 2.  Multi-step oxidations catalyzed by cytochrome P450 enzymes: Processive vs. distributive kinetics and the issue of carbonyl oxidation in chemical mechanisms.

Authors:  F Peter Guengerich; Christal D Sohl; Goutam Chowdhury
Journal:  Arch Biochem Biophys       Date:  2010-09-04       Impact factor: 4.013

3.  Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.

Authors:  S J Zimniski; M E Brandt; D F Covey; D Puett
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Conversion of 19-oxo[2 beta-2H]androgens into oestrogens by human placental aromatase. An unexpected stereochemical outcome.

Authors:  P A Cole; C H Robinson
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

5.  Conversion of a 3-desoxysteroid to 3-desoxyestrogen by human placental aromatase.

Authors:  P A Cole; J M Bean; C H Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.

Authors:  T Zaccheo; D Giudici; P Lombardi; E di Salle
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Metabolism of the steroidal aromatase inhibitor atamestane in rats, cynomolgus monkeys and humans. Isolation and identification of the major metabolites.

Authors:  W Kuhnz; G A Hoyer; S Backhus; U Jakobs
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

Review 8.  Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview.

Authors:  Eliot B Blatt; Noa Kopplin; Shourya Kumar; Ping Mu; Suzanne D Conzen; Ganesh V Raj
Journal:  Endocr Relat Cancer       Date:  2021-02       Impact factor: 5.678

9.  Mechanism of the third oxidative step in the conversion of androgens to estrogens by cytochrome P450 19A1 steroid aromatase.

Authors:  Francis K Yoshimoto; F Peter Guengerich
Journal:  J Am Chem Soc       Date:  2014-10-10       Impact factor: 15.419

Review 10.  Cytochrome P450 2E1 and its roles in disease.

Authors:  F Peter Guengerich
Journal:  Chem Biol Interact       Date:  2020-03-18       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.